Neil W Gibson - Net Worth and Insider Trading
Neil W Gibson Net Worth
The estimated net worth of Neil W Gibson is at least $730,811 dollars as of 2024-09-18. Neil W Gibson is the Director of TCR2 Therapeutics Inc and owns about 493,791 shares of TCR2 Therapeutics Inc (TCRR) stock worth over $730,811. Details can be seen in Neil W Gibson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil W Gibson has not made any transactions after 2020-03-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neil W Gibson
Neil W Gibson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil W Gibson owns 4 companies in total, including Shattuck Labs Inc (STTK) , TCR2 Therapeutics Inc (TCRR) , and Regulus Therapeutics Inc (RGLS) among others .
Click here to see the complete history of Neil W Gibson’s form 4 insider trades.
Insider Ownership Summary of Neil W Gibson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| STTK | Shattuck Labs Inc | 2020-10-08 | director |
| TCRR | TCR2 Therapeutics Inc | 2020-03-20 | director |
| RGLS | Regulus Therapeutics Inc | 2012-10-04 | Chief Scientific Officer |
 | | 2021-03-18 | director |
Neil W Gibson Latest Holdings Summary
Neil W Gibson currently owns a total of 1 stock. Neil W Gibson owns 493,791 shares of TCR2 Therapeutics Inc (TCRR) as of March 20, 2020, with a value of $730,811.
Latest Holdings of Neil W Gibson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRR | TCR2 Therapeutics Inc | 2020-03-20 | 493,791 | 1.48 | 730,811 |
Holding Weightings of Neil W Gibson
Neil W Gibson Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil W Gibson has made a total of 1 transactions in TCR2 Therapeutics Inc (TCRR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in TCR2 Therapeutics Inc is the sale of 79,640 shares on March 20, 2020, which brought Neil W Gibson around $524,828.
Insider Trading History of Neil W Gibson
- 1
Neil W Gibson Trading Performance
Neil W Gibson Ownership Network
Neil W Gibson Owned Company Details
What does Shattuck Labs Inc do?
Who are the key executives at Shattuck Labs Inc?
Neil W Gibson is the director of Shattuck Labs Inc. Other key executives at Shattuck Labs Inc include director & Chief Executive Officer Taylor Schreiber , See Remarks Stephen Stout , and See Remarks Andrew R Neill .
Shattuck Labs Inc (STTK) Insider Trades Summary
Over the past 18 months, Neil W Gibson made no insider transaction in Shattuck Labs Inc (STTK). Other recent insider transactions involving Shattuck Labs Inc (STTK) include a net sale of 25,000 shares made by Andrew R Neill , a net sale of 16,004 shares made by Stephen Stout , and a net purchase of 14,400 shares made by Taylor Schreiber .
In summary, during the past 3 months, insiders sold 0 shares of Shattuck Labs Inc (STTK) in total and bought 22,816 shares, with a net purchase of 22,816 shares. During the past 18 months, 41,004 shares of Shattuck Labs Inc (STTK) were sold and 22,816 shares were bought by its insiders, resulting in a net sale of 18,188 shares.
Shattuck Labs Inc (STTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shattuck Labs Inc Insider Transactions
Neil W Gibson Mailing Address
Above is the net worth, insider trading, and ownership report for Neil W Gibson. You might contact Neil W Gibson via mailing address: C/o Regulus Therapeutics Inc., 3545 John Hopkins Court Suite 210, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
